CD24 and cancer: Recently, Vasileva et al. [68] reported that the cell surface expression of CD24 is preferentially enriched in anastatic cancer (melanoma) cells that exhibit tumorigenic properties (also see the online article by Vijay Ulaganathan, one of the senior authors of this study [69]).